AAV Capsid Separation on Cation Exchanger
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating adeno-associated virus (AAV) in cell culture result in the formation of 'empty' capsids, which can induce immune responses and hepatotoxicity, necessitating the development of more effective purification techniques to separate full AAV capsids from empty ones.
Innovation Solution
A method involving a cation exchange column process using monovalent and divalent cations to selectively purify full AAV capsids from empty capsids, ensuring an AAV product substantially free of empty capsids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If current cell culture methods are used to generate AAV, then AAV production is achieved, but empty capsids are formed which induce immune responses and hepatotoxicity
Solution Approach 1:
The patent applies extraction by removing empty capsids from the AAV preparation through a cation exchange column process. The method selectively binds and elutes empty capsids separately from full capsids, effectively extracting the harmful empty particles from the therapeutic product to eliminate immune responses and hepatotoxicity.
Solution Approach 2:
The patent applies segmentation by dividing the AAV purification process into distinct stages using cation exchange chromatography. The process segments full capsids and empty capsids into separate fractions based on their different binding and elution characteristics, allowing selective collection of full capsids while removing empty ones.
2Object-affected harmful factors
If purification methods are added to remove empty capsids, then immune responses are reduced, but process complexity increases
Solution Approach 1:
The patent applies universality by using a single cation exchange column process that simultaneously achieves multiple purification objectives: removing empty capsids, concentrating full capsids, and eliminating other contaminants. This multi-functional approach reduces the need for multiple separate purification steps.
Solution Approach 2:
The patent applies parameter changes by optimizing buffer conditions including pH, ionic strength, and cation composition to achieve selective binding and elution of empty versus full capsids. By adjusting these parameters, the method achieves effective separation without requiring complex equipment or multiple process steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively separates full AAV capsids from empty capsids, reducing immune responses and hepatotoxicity, thereby enhancing the safety and efficacy of AAV-based gene therapy products.
Implementation Method 1
loading said first solution onto a cation exchange column under conditions whereby said full AAV capsids and said empty AAV capsids bind to the column
Data Source
AI summary
The present disclosure provides for a method of purifying adeno-associated virus comprising purifying full AAV capsids from a concentrated AAV fraction or preparation comprising empty AAV capsids and full AAV capsids. The present disclosure also provides for a method of purifying adeno-associated virus comprising purifying empty AAV capsids from a concentrated AAV fraction or preparation comprising empty AAV capsids and full AAV capsids. The method utilizes one or more monovalent and one or more divalent cations to effect the separation resulting in purified full AAV capsids or empty AAV capsids.